This study found Notch1, Notch2, and Notch4 to be involved in stromal-dependent CLL resistance to fludarabine and cyclophosphamide chemotherapy, with mesenchymal stem cells dramatically increasing tumor cell survival. Here, NOTCH2 is linked to neoplasm.